Ashley Spahn

Antigen-specific T cell responses to SARS-CoV-2 vaccination after Hematopoietic Cell Transplant or CAR T cell Therapy

Elad Sharon, Michael J. Martens, Joseph P. McGuirk, Min Chen et autres

us (code pays fourni par la source)

Antigen-specific T-cell responses to SARS-CoV-2 vaccination after hematopoietic cell transplant or CAR T-cell therapy

Sigrun Einarsdottir, Teng Fei, Katina H. Singh, Michael J. Martens et autres

us, gb, my, Afrique du Sud (code pays fourni par la source)

Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study

Jakob Wirbel, Wael Saber, Michael J. Martens, Jonathan U. Peled et autres

de, us (code pays fourni par la source)

Vδ2 unconventional T cells in the donor graft are associated with improved overall survival after unrelated donor allo-HCT for AML and MDS: An analysis from the DKMS and NMDP graft composition study

Kate A. Markey, Soyoung Kim, Gabrielle Schmidt, Michelle Kuxhausen et autres

Afrique du Sud, us, jp, de (code pays fourni par la source)

Leveraging Hematopoietic Cell Transplant Data and Biorepository Resources at the Center for International Blood and Marrow Transplant Research to Improve Patient Outcomes

Yung‐Tsi Bolon, Rasha Atshan, Mariam Allbee‐Johnson, Noel Estrada-Merly et autres

us (code pays fourni par la source)

SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study

Joshua A. Hill, Michael J. Martens, Jo‐Anne H. Young, Kavita V. Bhavsar et autres

us (code pays fourni par la source)

Sars-Cov-2 Vaccination in the First Year after Hematopoietic Cell Transplant or Chimeric Antigen Receptor T Cell Therapy: A CIBMTR and BMT CTN Study

Joshua A. Hill, Michael J. Martens, Jo‐Anne H. Young, Kavita V. Bhavsar et autres

us (code pays fourni par la source)

SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)

Joshua A. Hill, Michael J. Martens, Jo‐Anne H. Young, Kavita V. Bhavsar et autres

us, ie (code pays fourni par la source)

MAIT Cell Frequencies within PBSC Grafts Are Associated with Donor CMV Serostatus and Age: An Initial Analysis from the DKMS and NMDP Graft Composition Study

Hugh R. MacMillan, Hans Minderman, Ashley Spahn, Orla Maguire et autres

us, de (code pays fourni par la source)

Cryopreservation Changes the Immune Effector Cell Composition of Peripheral Blood Stem Cell Grafts: An Analysis from the DKMS and NMDP Graft Composition Study

Elke Rücker‐Braun, Bose Falk, Kate A. Markey, Hans Minderman et autres

de, us (code pays fourni par la source)

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

Joshua A. Hill, Michael J. Martens, Jo‐Anne H. Young, Kavita V. Bhavsar et autres

us (code pays fourni par la source)

Humoral Immunogenicity of Sars-Cov-2 Vaccination in the First Year after Hematopoietic Cell Transplant or Chimeric Antigen Receptor T Cell Therapy: A CIBMTR and BMT CTN Study

Marcie Riches, Joshua A. Hill, Michael Martens, Jeffery James Auletta et autres